Endoscopes are used to identify, diagnose, and treat malignant gastrointestinal (GI) disorders at an early stage. However, due to their complicated construction and wide range of applications in medical operations, the risk of infection transmission associated with endoscopes is generally considerable. As a result, health organizations in many countries have developed a strict endoscope reprocessing system.to increase safety and prevent the spread of infection. According to these regulations, endoscopes must go through several phases of thorough cleaning and disinfection before being used on patients. Many manufacturers are also introducing AERs (Automatic Endoscope Reprocessors) for consistent, accurate and cost-effective operation. By exposing the exterior surfaces and internal channels of reusable endoscopes to high-level disinfectants or liquid chemical sterilizing solutions, LDEs help destroy bacteria.
According to estimates from the American Cancer Society, the number of new cases of colorectal cancer in the United States at the end of 2018 reached 97,220, while the number of new cases of rectal cancer reached 43,030. This high incidence indicates the demand for screening by colonoscopic devices or sigmoidoscopic devices, which is further driving the growth of the market.
Data Bridge Market Research analyzes that the $1.85B Endoscope Reprocessing Market in 2021 will reach $3.45B in 2029 and is expected to grow at a CAGR of 8.10% during the forecast period 2022 to 2029. , growth rate, market segments, geographical coverage, market players and market scenario, the market report organized by Data Bridge Market Market Research team also includes detailed expert analysis, epidemiology of the patient, channeling analysis, price analysis and regulatory framework.
Some of the major players operating in the endoscope reprocessing market are:
- Cantel Medical (United States)
- ASP (USA)
- Olympus Corporation (Japan)
- Ecolab (USA)
- STERIS (Ireland)
- Getinge AB (Sweden)
- Wassenburg Medical (Netherlands)
- CONMED Corporation (USA)
- Belimed SA (Switzerland)
- Endo-Technik W. Griesat (Germany)
- Custom Ultrasound.com (USA)
- Steelco SpA (Italy)
- BES Rehab Ltd (UK)
- ARC Group of Companies Inc. (Canada)
- Metrex Research, LLC. (Canada)
- Richard Wolf GmbH (Germany)
- MEDALKAN (Greece)
- Micro-Scientific, LLC (USA)
- Borer Chemie AG (Switzerland)
- Tuttnauer (Netherlands)
- GAB (Canada)
- Summit Imaging, Inc. (USA)
- Medonica Co. LTD (South Korea)
- SHINVA MEDICAL INSTRUMENT CO. LTD (China)
- Medical Devices Group Srl (Italy)
For More Information On Market Analysis, View Research Report Summary At https://www.databridgemarketresearch.com/reports/us-endoscope-reprocessing-market
Endoscope Reprocessing Market Dynamics
- Increased prevalence of digestive diseases
The increase in the prevalence of digestive diseases due to changes in lifestyles has led to an increase in endoscopic examinations, driving the market. During the forecast period of 2029, the increasing prevalence of innovative product launches for patient safety will generate new opportunities that will affect the growth of the endoscope reprocessing market. In April, Advanced Sterilization Products (ASP) received 510(k) certifications for its ASP AEROFLEX AER automated endoscope reprocessor. It is the fastest, with a cycle time of 22 minutes. As a new product, it will lead to increased revenue and expansion of the product portfolio.
- Increase endoscopic devices
The rising incidence of endoscopy-related infections, increased hospital investments in endoscopy tools, and the growing number of disorders requiring endoscopic operations are driving the endoscope reprocessing market. Endoscopic devices are most commonly used in disease detection and therapy. The increasing prevalence of endoscopy-detectable disorders has increased the demand for these devices.
- Growing desire for procedures
Desired procedures result in faster recovery, fewer postoperative infections, less discomfort, less scarring, better bleeding control, and greater precision is expected to increase the demand for various endoscopic devices. Major industry players are working to gain approval for new items to expand their product portfolio. For example, Advanced Sterilization Products’ ASP AEROFLEX automated endoscope reprocessor was approved by the US Food and Drug Administration in April 2019. Due to the increasing number of endoscopic reprocessing devices on the market, the industry should grow rapidly. .
The demand for flexible endoscopes to identify and treat cancer and gastrointestinal diseases is driven by the growing pediatric population, which is more vulnerable to specific diseases. Endoscopy devices are also used to explore atypical symptoms such as dysphagia, diarrhea, weight loss, heartburn, and blood in the stool, leading to the development of endoscope reprocessing to reduce the risk of infection. In addition, healthcare organizations are implementing facility-level training programs to help healthcare facilities achieve consistent, high-quality endoscope reprocessing. This, combined with an increasing focus on improving reprocessing criteria,
Scope of the US endoscope reprocessing market USA
The endoscope reprocessing market is segmented based on products, modalities, process type, and end user. Growth between these segments will help you analyze weak growth segments in industries and provide users with valuable market information and market insights to help them make strategic decisions to identify leading market applications.
- Benchtop Endoscopic Reprocessors
- Autonomous endoscopic reprocessors
- Automated Cleaning Sanitizers
- Manual cleaning solutions
Automated Blood Tube Labeler – Specimen Transport Box Market– Size, Shares, Trends and Industry Growth Outlook https://www.databridgemarketresearch.com/reports/global-automated-blood-tube-labeler-specimen-transport-box-market
North America Drug Delivery Devices Market– Size, Shares, Trends and Industry Growth Outlook https://www.databridgemarketresearch.com/reports/north-america-drug-delivery-devices-market
Asia-Pacific Drug Delivery Devices Market– Size, Shares, Trends and Industry Growth Outlook https://www.databridgemarketresearch.com/reports/asia-pacific-apac-drug-delivery-devices-market
Transmucosal Drug Delivery Devices Market – Size, Shares, Trends and Industry Growth Outlook https://www.databridgemarketresearch.com/reports/global-transmucosal-drug-delivery-devices-market
China Injectable Drug Delivery Devices Market – Size, Shares, Trends and Industry Growth Outlook https://www.databridgemarketresearch.com/reports/china-injectable-drug-delivery-devices-market
COVID-19 Drug Delivery Devices Market– Size, Shares, Trends and Industry Growth Outlook https://www.databridgemarketresearch.com/reports/global-covid-19-drug-delivery-devices-market
Connected Drug Delivery Devices Market – Size, Shares, Trends and Industry Growth Outlook https://www.databridgemarketresearch.com/reports/global-connected-drug-delivery-devices-market
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- [email protected]